Community Research and Development Information Service - CORDIS

FP5

Innovation and competitiveness in European biotechnology

Funded under: FP5-INNOVATION-SME

Abstract

The biotechnology sector is characterised by a new breed of small, dedicated biotechnology firms (DBFs), that have entered the industry with the explicit aim of exploiting the new technologies of life sciences for different industrial purposes.

This report examines innovative activities in the European biotechnlogy industry, and institutional factors that affect industrial competitivelness in biotechnology. It concludes that higher degrees of pluralism in finding sources, lower dependence on closed national systems, higher integration of research with teaching, clinical research and medical practice, together with a higher reliance on interdisciplinary research teams in the life sciences, should become priorities of a European research policy on biotechnology.

The report is published by the European Commission, DG Enterprise as: Enterprise Papers - No. 7, 2002

Download application/pdf (835007)

Record Number: 1758 / Last updated on: 2002-01-30
Category: STUD